Kaleido Biosciences, Inc. (KLDO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 26, 2026, 12:26 PM EST

Kaleido Biosciences Revenue

In the year 2021, Kaleido Biosciences had annual revenue of $1.10M with 13.23% growth. Kaleido Biosciences had revenue of $492.00K in the quarter ending December 31, 2021, with 102.47% growth.

Revenue
1.10M
Revenue Growth
+13.23%
P/S Ratio
0.00
Revenue / Employee
14.53K
Employees
76
Market Cap
4.26K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20211.10M129.00K13.23%
Dec 31, 2020975.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ONE Bio53.91M
Affimed6.29M
Hemagen Diagnostics4.04M
MultiCell Technologies805.24K
Entia Biosciences265.47K
MetaStat23.30K
Revenue Rankings